Wesley Thomas Richerson1, Megan Aumann1, Alex Song1, Jarrod Eisma1, Samantha Davis2, Lauren Milner2, Lori Jordan1,2,3, and Manus Donahue1,4,5
1Neurology, Vanderbilt University Medical Center, Nashville, TN, United States, 2Pediatrics, Vanderbilt University Medical Center, Nashville, TN, United States, 3Radiology, Vanderbilt University Medical Center, Nashville, TN, United States, 4Psychiatry, Vanderbilt University Medical Center, Nashville, TN, United States, 5Electrical and Computer Engineering, Vanderbilt University, Nashville, TN, United States
Synopsis
Keywords: Blood Vessels, Arterial spin labelling, Sickle Cell Disease, White Matter Perfusion
Motivation: Accurate white matter (WM) perfusion quantification is difficult but likely critical for assessing infarct risk in Sickle Cell Disease (SCD).
Goal(s): To evaluate the feasibility of detecting regional WM perfusion using arterial spin labeling (ASL) under conditions of high perfusion and reduced bolus arrival time (BAT) in SCD patients.
Approach: A multi-inversion time (TI; range=200-3200 ms), pulsed ASL sequence was applied to quantify perfusion detectability in SCD (n=35) and healthy (n=15) participants.
Results: WM perfusion was significantly detected for TI=800-1800 ms in SCD patients. BAT in SCD was more closely related to hematocrit (rho=0.43; p=0.01) than was WM perfusion (rho=-0.13; p=0.47).
Impact: We provide evidence in support of perfusion detection with
ASL in SCD patients, which is attributable to higher perfusion and reduced BAT.
Introduction
The goals of this work
are to: (1) revisit the possibility of quantifying white matter (WM) cerebral
blood flow (CBF) with 3-Tesla arterial spin labeling (ASL) MRI, using recent
sequence and hardware advances, over a range of inversion times (TIs) and (2)
quantify CBF in healthy adults and adults with elevated CBF and reduced bolus
arrival time (BAT) secondary to sickle cell disease (SCD). Despite the majority
of silent and overt infarcts being localized to WM, ASL has been demonstrated to
lack WM CBF sensitivity owing to lower WM CBF and longer WM BAT compared to
blood-water T11,2. However, increased CBF and decreased BAT in
SCD patients, and recent ASL advances, may enable WM CBF quantification3,4. We performed multi-delay Look-Locker ASL in
healthy and SCD participants, quantified signal reliability over a range of CBF
and BAT, and collected T2-Relaxation-Under-Spin-Tagging
(TRUST) to estimate global oxygen extraction fraction (OEF) and further
cerebral metabolic rate of oxygen (CMRO2). In an exploratory
analysis, we tested the relationships between (i) CBF and hematocrit, (ii) BAT
and hematocrit, and (iii) BAT and CMRO2.Methods
35 SCD (hemoglobin-SS)
and 15 healthy age-matched (hemoglobin-AA) adults provided informed consent.
Total hemoglobin and hemoglobin-S fraction were evaluated on the day of the
scan in SCD patients. Participants were scanned at 3-Tesla using a novel pulsed
ASL (PASL) sequence (repetitions=25; TIs=16; TI-range=200-3200ms;
resolution=3x3x7mm; slices=9; acquisition time=6min56s) with Look-Locker
readout and labeling 100 mm proximal to the imaging volume. We additionally
collected a TRUST sequence for OEF quantification using a human hemoglobin
calibration model.
Using the CBF-weighted
signal (ΔM/M0), we performed one-sample t-tests at each TI comparing
the signal measured to null signal5 and used mean ΔM/M0 over time and
FSL-BASIL to fit the three-stage kinetic model for CBF and BAT, accounting for hematocrit
effect on arterial blood T16,7,8. CBF was quantified in total gray matter (GM)
and WM; as well as anterior, middle, and anterior-middle cerebral artery
border-zone WM territories9. CBF, OEF, arterial oxygen saturation and
hemoglobin levels were then used in Fick’s Principle to estimate CMRO210.Results
Signal was one
standard deviation above significance criteria in the WM for each group
(controls: TI=1400ms, SCD: TI=800-1800ms), peaking at TI=1200ms in SCD and
TI=1400ms in controls (Figure 1). Border-zone ASL signal was detected at
TI=1400ms in SCD, but was not detected in controls. SCD CBF was observed to be
significantly higher across all regions relative to controls (SCD CBF: GM=63.7±20.1mL/100g/min
and WM=19.2±7.5mL/100g/min; Control CBF: GM=36.3±9.3mL/100g/min and WM=8.7±2.0mL/100g/min),
but only total WM BAT was reduced in SCD relative to healthy participants
(Control BAT: GM=629±76ms and WM=923±65ms; SCD BAT: GM=601±84ms and WM=876±86ms)
(Figures 2-3), indicating that low CBF, rather than prolonged BAT, may be most
relevant to WM CBF detectability issues. WM CBF was not associated with hematocrit
(Spearman-ρ=-0.20; p=0.26), but
BAT was significantly associated with hematocrit (Spearman-ρ=0.55; p<0.001).
Additionally, GM BAT was significantly associated with GM CMRO2 (Spearman-ρ=-0.34;
p=0.049).Conclusions
We used a novel PASL
sequence to demonstrate the feasibility of quantifying WM CBF in healthy and
SCD participants and report that WM CBF quantification in major flow
territories is more viable than previously appreciated even for healthy
hemoglobin levels. Additionally, in exploratory analyses we found BAT to be
related to hematocrit and CMRO2, confirming prior studies that blood
flow kinetics are dependent on hematocrit; how such accelerated flow velocities
influence oxygen extraction and consumption in the setting of SCD is a topic of
ongoing investigation.Acknowledgements
No acknowledgement found.References
1. Ford AL,
Ragan DK, Fellah S, et al. Silent infarcts in sickle cell disease occur in the
border zone region and are associated with low cerebral blood flow. Blood
2018; 132: 1714–1723.
2. van Gelderen P, de Zwart J a., Duyn J h. Pittfalls of MRI
measurement of white matter perfusion based on arterial spin labeling. Magnetic
Resonance in Medicine 2008; 59: 788–795.
3. Bush A, Chai Y, Choi SY, et al. Pseudo Continuous Arterial Spin
Labeling Quantification in Anemic Subjects with Hyperemic Cerebral Blood Flow. Magn
Reson Imaging 2018; 47: 137–146.
4. Juttukonda MR, Jordan LC, Gindville MC, et al. Cerebral
hemodynamics and pseudo-continuous arterial spin labeling considerations in
adults with sickle cell anemia. NMR in Biomedicine 2017; 30: 1–9.
5.
van Osch MJP, Teeuwisse WM, van
Walderveen MAA, et al. Can arterial spin
labeling detect white matter perfusion signal? Magnetic Resonance in
Medicine 2009; 62: 165–173.
6. Buxton RB, Frank LR, Wong EC, et al. A general kinetic model
for quantitative perfusion imaging with arterial spin labeling. Magnetic
Resonance in Medicine 1998; 40: 383–396.
7. Chappell MA, MacIntosh BJ, Donahue MJ, et al. Separation of
macrovascular signal in multi-inversion time arterial spin labelling MRI. Magnetic
Resonance in Medicine 2010; 63: 1357–1365.
8. Lu H, Clingman C, Golay X, et al. Determining the longitudinal
relaxation time (T1) of blood at 3.0 Tesla. Magnetic Resonance in Medicine
2004; 52: 679–682.
9. Liu C-F, Hsu J, Xu X, et al. Digital 3D Brain MRI Arterial
Territories Atlas. Sci Data 2023; 10: 74.
10. Kety SS, Schmidt CF. The Effects of Altered Arterial Tensions of
Carbon Dioxide and Oxygen on Cerebral Blood Flow and Cerebral Oxygen
Consumption of Normal Young Men. J Clin Invest 1948; 27: 484–492.